Medpace Holdings, Inc. Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP

주식 순위 #1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
주가
$621.67
시가총액
$17.35B
변동 (1일)
0.52%
변동 (1년)
17.72%
국가
US
거래 Medpace Holdings, Inc. (MEDP)

카테고리

Healthcare
Medpace Holdings, Inc. (MEDP)의 EPS
June 2026 기준 EPS TTM: $17.39
Medpace Holdings, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $17.39입니다. 2024년 말에는 회사의 EPS가 $13.06였으며, 이는 2023년의 EPS $9.20와 감소입니다.
Medpace Holdings, Inc.의 EPS 기록 (2013 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $17.39 11.19%
2025 $15.64 19.75%
2024 $13.06 41.96%
2023 $9.20 21.53%
2022 $7.57 49.60%
2021 $5.06 24.32%
2020 $4.07 45.88%
2019 $2.79 36.10%
2018 $2.05 105.00%
2017 $1.00 163.16%
2016 $0.38 -235.71%
2015 $-0.28 -47.17%
2014 $-0.53 -139.85%
2013 $1.33 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$18.62 7.07%
US
$5.65 -67.51%
US
$-1.36 -107.82%
US
- -
CN
$5.09 -70.73%
US